Bullseye Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-41,425
Closed -$2.58M 72
2023
Q4
$2.58M Hold
41,425
1.23% 33
2023
Q3
$2.33M Hold
41,425
1.3% 33
2023
Q2
$2.09M Buy
41,425
+3,431
+9% +$183K 1.05% 39
2023
Q1
$2.07M Hold
37,994
1.06% 41
2022
Q4
$2.38M Hold
37,994
1.29% 32
2022
Q3
$2.68M Sell
37,994
-449
-1% -$31K 1.56% 26
2022
Q2
$2.18M Buy
38,443
+40
+0.1% +$2.19K 1.23% 38
2022
Q1
$2.4M Hold
38,403
1.11% 43
2021
Q4
$2.13M Hold
38,403
0.84% 48
2021
Q3
$2.5M Sell
38,403
-103
-0.3% -$7.03K 0.87% 43
2021
Q2
$2.44M Hold
38,506
0.82% 52
2021
Q1
$2.31M Hold
38,506
0.86% 50
2020
Q4
$1.92M Sell
38,506
-314
-0.8% -$14.7K 0.72% 54
2020
Q3
$1.98M Sell
38,820
-23
-0.1% -$960 0.9% 43
2020
Q2
$1.36M Buy
38,843
+10,114
+35% +$348K 0.73% 56
2020
Q1
$730K Sell
28,729
-209
-0.7% -$6.21K 0.87% 40
2019
Q4
$802K Buy
+28,938
New +$691K 0.78% 46

Other funds holding AXNX

Bullseye Asset Management's AXNX Position: Q1 2024 in Review

Bullseye Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 41,425 shares — an estimated $2.58M sold.

Bullseye Asset Management first reported a position in AXNX in Q4 2019 and held it in 17 quarters. The position peaked at $2.68M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Bullseye Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bullseye Asset Management sold 41,425 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $2.58M.
  • Bullseye Asset Management first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
  • Bullseye Asset Management's Axonics, Inc. Common Stock position peaked at $2.68M in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Bullseye Asset Management's 13F filing for Q1 2024, filed 14 May 2024.